The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119720609 11972060 9 F 20160122 20160829 20160128 20160906 EXP PHHY2016LB008493 NOVARTIS 36.28 YR F Y 0.00000 20160906 MD LB LB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119720609 11972060 1 PS TASIGNA NILOTINIB 1 Oral 600 MG, QD U 22068 600 MG CAPSULE QD
119720609 11972060 2 C EUTHYROX LEVOTHYROXINE SODIUM 1 Oral 100 UG, QD 0 100 UG QD
119720609 11972060 3 C EUTHYROX LEVOTHYROXINE SODIUM 1 Oral 150 UG, QD 0 150 UG QD
119720609 11972060 4 C ZYLORIC ALLOPURINOL 1 Oral 300 MG, FOR 10 DAYS PER MONTH U 0 300 MG
119720609 11972060 5 C EURO D 2 Oral 1 DF, EVERY 3 DAYS U 0 1 DF TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119720609 11972060 1 Chronic myeloid leukaemia
119720609 11972060 2 Product used for unknown indication
119720609 11972060 4 Product used for unknown indication
119720609 11972060 5 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
119720609 11972060 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
119720609 11972060 Abdominal distension
119720609 11972060 Abdominal pain
119720609 11972060 Abdominal pain upper
119720609 11972060 Anaemia
119720609 11972060 Anxiety
119720609 11972060 Arthralgia
119720609 11972060 Back pain
119720609 11972060 Bone pain
119720609 11972060 Burning sensation
119720609 11972060 Chest pain
119720609 11972060 Dizziness
119720609 11972060 Ear pain
119720609 11972060 Fatigue
119720609 11972060 Granuloma skin
119720609 11972060 Menstrual disorder
119720609 11972060 Nervousness
119720609 11972060 Oedema peripheral
119720609 11972060 Oropharyngeal pain
119720609 11972060 Ovarian cyst
119720609 11972060 Pelvic fluid collection
119720609 11972060 Pelvic pain
119720609 11972060 Rectal haemorrhage
119720609 11972060 Splenomegaly
119720609 11972060 Thyroid disorder
119720609 11972060 Tooth disorder
119720609 11972060 Vaginal infection
119720609 11972060 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119720609 11972060 1 20160113 0
119720609 11972060 2 2007 0
119720609 11972060 3 20160118 0